Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Silibinin may help hair growth and treat hair loss.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Serenoa repens extract helps regrow hair and repair hair loss by activating certain cell growth pathways.

Bilobetin may help reduce acne by decreasing sebum production.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Compound 7p shows strong potential as an anticancer agent.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Erlotinib can cause persistent excessive hair growth.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.